Laura Comilla

Commercial Director Americas, LTS Health

Laura Comilla has helped lead change and transformation in over 200 labs across the world. She has worked in diverse environments—from rural African communities to advanced technology labs, and her laboratory exposure is vast—from microbiology and anatomic pathology to molecular/genetics and chemistry, and more. Laura came to LTS Health from the medical device industry, where she developed her background in solution design and marketing for laboratory services and informatic solutions. LTS Health is a leader in the medical laboratory field, with 20 years’ experience in designing and implementing sustainable solutions for the diagnostics industry. These include consolidation, automation and new technology selection. Their solutions are enabled by technology and often include accredited training to equip organizations with a continuous improvement mindset. Laura studied Biochemistry and Biotechnology at Michigan State University and completed her master’s degree in chemistry from DePaul University in Chicago. She is certified in Operational Excellence from the American Society of Quality and Change Management. She is an active member of the Healthcare Businesswomen’s Association and the Clinical Laboratory Management Association. Laura also mentors undergraduates from her alma mater, Michigan State, as they enter the field of laboratory medicine. At Lab Institute 2018, Laura is presenting on the topic of Breaking Down Barriers. She will share what LTS Health learned from leading England’s national program for pathology benchmarking, consolidation, and service improvement.

Laura is speaking at

Track: Adding Value to Your Lab
October 25, 2018
1:30 pm - 2:20 pm
Regency D

Speaker

  • Laura Comilla (Speaker) Commercial Director Americas, LTS Health

Description

In this presentation, Ms. Comilla will discuss the approach LTS Health used to lead the UK NHS consolidation plan, which is transferable to USA health systems. The approach was initially applied to pathology labs and has now been extended to imaging, which has started Phase 1.

This consolidation plan had three phases:

Phase 1: Workforce efficiency benchmarking
Defining, collecting, and reporting the system operational metrics for 110 pathology service providers (laboratory systems). LTS Health also worked with each of the 110 providers to reduce the variances seen amongst the groups, yielding $40MM per year savings.

Phase 2: Consolidation
Through the creation of a national dataset, consolidation planning reduced 110 pathology service providers to only 29. LTS Health worked across health systems to identify the optimal locations to remain as full-service providers. This yielded additional yearly savings of $300MM.

Phase 3: Business process optimization
By working closely with each provider, LTS Health optimizes its processes based on individual requirements and challenges. This includes, but is not limited to, managing population cost variation, new reimbursement opportunities and the reduction of wasteful tests.

Learning Objectives:

  • Identify the requirements for data collection and benchmarking
  • Outline best practices for publishing health data
  • Conceptualize the consolidation model and considerations to achieve national consolidation

Add to my calendar

Google

Create your personal schedule through the official app, Whova!

Get Started